Trudell Medical Limited named one of Canada's Best Managed Companies for 2023

Adherium Limited (ASX:ADR), a leader in digital inhaled device adherence, remote monitoring and data management solutions, is pleased to announce agreement of terms with leading respiratory company Monaghan Medical Corporation (Monaghan) to support the introduction of its Hailie^® platform and technology into specialist respiratory centres in the United States

PLATTSBURGH, NY (November 5, 2020) – Monaghan Medical Corporation (MMC) today announced the opening of a new 65,000-square-foot facility that doubles the size of its previous headquarters building. The new facility will house Monaghan Medical’s warehouse, production, administration, and all support functions, and the campus property has room to double the plant’s square footage for future expansion.

Melbourne, Australia – 29 April 2020: Adherium Limited (ASX:ADR), a leader in digital inhaled device adherence, remote monitoring and data management solutions, has signed a heads of terms sales agreement with Monaghan Medical Corporation, a US subsidiary of Trudell Medical Limited, a parent company of a multinational group of leading companies in the medical device and healthcare service sectors, including Trudell Medical International.  Monaghan is a leader in the development and manufacture of innovative, high quality, patient-oriented aerosol drug delivery devices and respiratory management solutions in the United States.  

Trudell Medical Limited has invested in Adherium (Australia) as part of the company’s strategic plan to support organizations with innovative technologies that improve patient outcomes. Adherium is a provider of digital health solutions and a global leader in connected respiratory medical devices, with more than 170,000 sold globally. The company develops, manufactures and supplies a broad range of connected medical devices for respiratory medications for patients, pharmaceutical companies, healthcare providers and contract research organizations.  Trudell subscribed $1,126,000 million of secured debt notes. The funds raised from the issue will be used for working capital purposes.

Monaghan Medical Corporation (MMC) has received the prestigious American Association of Respiratory Care (AARC) Zenith Award for the fifth consecutive year.  The award was presented at the 65th International Respiratory Care Convention and Exhibition in New Orleans, Louisiana.